This company listing is no longer active
1D8 Stock Overview
Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Singapore O&G Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.28 |
52 Week High | S$0.30 |
52 Week Low | S$0.24 |
Beta | 0.88 |
11 Month Change | 0% |
3 Month Change | -5.09% |
1 Year Change | 7.69% |
33 Year Change | -25.33% |
5 Year Change | -56.92% |
Change since IPO | -11.81% |
Recent News & Updates
Recent updates
Shareholder Returns
1D8 | SG Healthcare | SG Market | |
---|---|---|---|
7D | 0% | 0.4% | 0.5% |
1Y | 7.7% | -11.7% | 14.1% |
Return vs Industry: 1D8 exceeded the SG Healthcare industry which returned -8.6% over the past year.
Return vs Market: 1D8 exceeded the SG Market which returned -3% over the past year.
Price Volatility
1D8 volatility | |
---|---|
1D8 Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.6% |
10% most volatile stocks in SG Market | 14.4% |
10% least volatile stocks in SG Market | 2.1% |
Stable Share Price: 1D8 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 1D8's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 83 | Eric Choo | www.sog.com.sg |
Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore. The company operates through four segments: Obstetrics and Gynaecology, Cancer-Related, Dermatology, and Paediatrics. It offers general obstetrics, labor, and delivery; medical problems in pregnancy; and obstetrical complications and its management.
Singapore O&G Ltd. Fundamentals Summary
1D8 fundamental statistics | |
---|---|
Market cap | S$133.66m |
Earnings (TTM) | S$8.36m |
Revenue (TTM) | S$42.66m |
16.0x
P/E Ratio3.1x
P/S RatioIs 1D8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1D8 income statement (TTM) | |
---|---|
Revenue | S$42.66m |
Cost of Revenue | S$28.36m |
Gross Profit | S$14.30m |
Other Expenses | S$5.93m |
Earnings | S$8.36m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 11, 2022
Earnings per share (EPS) | 0.018 |
Gross Margin | 33.51% |
Net Profit Margin | 19.60% |
Debt/Equity Ratio | 0% |
How did 1D8 perform over the long term?
See historical performance and comparison